Vasodilator Agent

News

February 07, 2022

2 min read

Save

Vasodilators underused for Raynaud's phenomenon, early systemic sclerosis in veterans

Vasodilator therapy may be underused for Raynaud’s phenomenon and very early systemic sclerosis in U.S. veterans deployed in post-9/11 military operations, according to data published in BMC Rheumatology.

Part of the Healio Network

Hydralazine

Hydralazine is a direct arterial vasodilator and is used for the treatment of hypertension and heart failure.